Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species.

Candida albicans fluconazole tolerance pitavastatin calcium reactive oxygen species ubiquinone biosynthesis

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
29 May 2024
Historique:
received: 27 03 2024
revised: 28 05 2024
accepted: 28 05 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Fluconazole (FLC) is extensively employed for the prophylaxis and treatment of invasive fungal infections (IFIs). However, the fungistatic nature of FLC renders pathogenic fungi capable of developing tolerance towards it. Consequently, converting FLC into a fungicidal agent using adjuvants assumes significance to circumvent FLC resistance and the perpetuation of fungal infections. This drug repurposing study has successfully identified pitavastatin calcium (PIT) as a promising adjuvant for enhancing the fungicidal activity of FLC from a comprehensive library of 2372 FDA-approved drugs. PIT could render FLC fungicidal even at concentrations as low as 1 μM. The median lethal dose (LD

Identifiants

pubmed: 38929106
pii: antiox13060667
doi: 10.3390/antiox13060667
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Key Research and Development Program of China
ID : 2022YFC2303004
Organisme : National Key Research and Development Program of China
ID : 2021YFC2300404
Organisme : National Natural Science Foundation of China
ID : 82020108032
Organisme : Innovation Program of Shanghai Municipal Education Commission
ID : 202101070007-E00094

Auteurs

Wanqian Li (W)

Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.

Yanru Feng (Y)

Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.

Zhe Feng (Z)

Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.

Li Wang (L)

Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.

Malcolm Whiteway (M)

Department of Biology, Concordia University, Montreal, QC H4B 1R6, Canada.

Hui Lu (H)

Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.

Yuanying Jiang (Y)

Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.

Classifications MeSH